Griffith appoints inaugural Executive Director for new Institute for Biomedicine and Glycomics
Professor Paul Clarke will join the University as the inaugural Executive Director of the new Institute for Biomedicine and Glycomics.
Professor Paul Clarke will join the University as the inaugural Executive Director of the new Institute for Biomedicine and Glycomics.
A $2 million grant awarded to establish the Queensland Drug Discovery Alliance (QDDA) will align and grow Queensland’s small molecule therapeutic discovery capability under the leadership of Therapeutic Innovation Australia (TIA).
Native Charge Detection Mass Spectrometry will enable cross-collaboration research to develop life-changing therapies, vaccines and diagnostics.
In a significant breakthrough, researchers from the Swiss Tropical and Public Health Institute (Swiss TPH) and Griffith University’s Institute for...
The first week of October brought with it a flurry of activity at Griffith University’s Institute for Glycomics as they...
Griffith University researchers are on the brink of a technological breakthrough in vaccine development with a possible new vaccine modality.
Controlling the size and shape of virus proteins can support development of new vaccines and delivery systems.
Griffith University’s world-first study into cell transplantation to repair injuries to the nervous system has received a major boost thanks to a $5.4 million funding extension from the MAIC.
Griffith research has been funded nearly $900,000 by the National Breast Cancer Foundation (NBCF) of Australia following discovery of a surprising new strategy for the treatment of one of the most common types of breast cancer.
Griffith University is paying tribute to one of its finest in Professor Emeritus Alan Mackay-Sim AM known to many as...